menu search

STTK / Shattuck Labs, Inc. (STTK) Q3 2022 Earnings Call Transcript

Shattuck Labs, Inc. (STTK) Q3 2022 Earnings Call Transcript
Shattuck Labs, Inc. (NASDAQ:STTK ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Conor Richardson - Senior Director of Finance and Investor Relations Taylor Schreiber - Chief Executive Officer Lini Pandite - Chief Medical Officer Andrew Neill - Chief Financial Officer Conference Call Participants Marc Frahm - Cowen Gil Blum - Needham & Company Carly Kenselaar - Citi Kaveri Pohlman - BTIG Zhiqiang Shu - Berenberg Operator Good afternoon, everyone, and welcome to Shattuck Labs Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. Read More
Posted: Nov 12 2022, 06:47
Author Name: Seeking Alpha
Views: 110625

STTK News  

Shattuck Labs, Inc. (STTK) Reports Q2 Loss, Lags Revenue Estimates

By Zacks Investment Research
August 10, 2023

Shattuck Labs, Inc. (STTK) Reports Q2 Loss, Lags Revenue Estimates

Shattuck Labs, Inc. (STTK) came out with a quarterly loss of $0.50 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to more_horizontal

Shattuck Labs to Present Complete Dose-Escalation Data from Phase 1A Monotherapy Clinical Trial of SL-172154 in Platinum-Resistant Ovarian Cancer (PROC) at the American Society of Clinical Oncology (A

By GlobeNewsWire
May 25, 2023

Shattuck Labs to Present Complete Dose-Escalation Data from Phase 1A Monotherapy Clinical Trial of SL-172154 in Platinum-Resistant Ovarian Cancer (PROC) at the American Society of Clinical Oncology (A

- SL-172154 demonstrated favorable safety and tolerability profile across doses, with maximal CD47 and CD40 target engagement and CD40-dependent pharm more_horizontal

Shattuck Labs to Present Complete Dose-Escalation Data from Phase 1A Monotherapy Clinical Trial of SL-172154 in Platinum-Resistant Ovarian Cancer (PROC) at the American Society of Clinical Oncology (A

By GlobeNewsWire
May 25, 2023

Shattuck Labs to Present Complete Dose-Escalation Data from Phase 1A Monotherapy Clinical Trial of SL-172154 in Platinum-Resistant Ovarian Cancer (PROC) at the American Society of Clinical Oncology (A

- SL-172154 demonstrated favorable safety and tolerability profile across doses, with maximal CD47 and CD40 target engagement and CD40-dependent pharm more_horizontal

Shattuck Labs, Inc. (STTK) Reports Q1 Loss, Misses Revenue Estimates

By Zacks Investment Research
May 9, 2023

Shattuck Labs, Inc. (STTK) Reports Q1 Loss, Misses Revenue Estimates

Shattuck Labs, Inc. (STTK) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to more_horizontal

Shattuck Labs, Inc. (STTK) Q4 2022 Earnings Call Transcript

By Seeking Alpha
February 26, 2023

Shattuck Labs, Inc. (STTK) Q4 2022 Earnings Call Transcript

Shattuck Labs, Inc. (NASDAQ:STTK ) Q4 2022 Earnings Conference Call February 23, 2023 4:45 PM ET Company Participants Conor Richardson - Vice Presiden more_horizontal

Shattuck Labs, Inc. (STTK) Q3 2022 Earnings Call Transcript

By Seeking Alpha
November 12, 2022

Shattuck Labs, Inc. (STTK) Q3 2022 Earnings Call Transcript

Shattuck Labs, Inc. (NASDAQ:STTK ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Conor Richardson - Senior Directo more_horizontal

Should You Buy Shattuck Labs (STTK) Ahead of Earnings?

By Zacks Investment Research
May 13, 2022

Should You Buy Shattuck Labs (STTK) Ahead of Earnings?

Shattuck Labs (STTK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. more_horizontal

Shattuck Labs to Present Two Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting

By GlobeNewsWire
March 9, 2022

Shattuck Labs to Present Two Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting

AUSTIN, Texas and DURHAM, N.C., March 09, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology compa more_horizontal


Search within

Pages Search Results: